Several reports have emphasized that putative laboratory surrogates of nutrition, such as serum albumin, creatinine, and cholesterol concentrations are statistically more powerful independent predictors of odds riks of death for dialysis patients than is the delivered dose of dialysis. In view of the relative simplicity with which these blood tests can be obtained, their lack of expense, and simplicity in interpretation, the dialysis community has greatly escalated their importance as performance measures for the processes of patient care, arguably without full consideration of their meaning. If malnutrition in dialysis patients is a powerful predictor of death risk, and is amenable to corrective interventions that result in a reduction in the odds risk of death, then the zeal with which these laboratory tests have been embraced is appropriate. However, the assumption that a statistical correlation between laboratory surrogates of malnutrition, or other measures of inadequate nutrition, such as body mass index or a subjective global assessment, indicate a direct causal relationship between nutritional intake, nutritional status, and outcome may be incorrect. Such apparent linkages may be a consequence of the statistical model selected alone, i.e., another unappreciated medical condition may be the proximate cause of death in addition to resulting in malnutrition. The mechanism(s) by which malnutrition may adversely impact the survival of end-stage renal disease (ESRD) patients is unclear. The impact of milder degrees of malnutrition on patient survival, their proximate effect on survival, and the reality of their independent effect on patient survival are also inadequately defined. Clearly, there is a statistical link between the putative laboratory surrogates of nutrition and patient survival. Regardless of the pathobiology of such a causal link, it is valid to enquire if an intervention that results in a positive change in nutritional parameters enhances patient survival. These issues surrounding nutritional status and survival in patients with ESRD are reviewed here in detail. The conclusion of this critique is that additional studies are needed to determine if malnutrition is truly an independent and responsive predictor of outcome for ESRD patients.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.